Premium
Isotec (MM) (ISOT)
NASDAQ
Hot Features
Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.
IRVINE, California, October 29 /PRNewswire-FirstCall/ -- IsoTis, Inc. (NASDAQ:ISOT) ("IsoTis"), an orthobiologics company, today announced that, at the special meeting of stockholders...
IRVINE, California, October 29 /PRNewswire-FirstCall/ -- IsoTis, Inc. (NASDAQ:ISOT) ("IsoTis"), an orthobiologics company, today announced that, at the special meeting of stockholders...
Less Than 40,000 Additional "FOR" Votes Required for Integra Merger IRVINE, California, October 26 /PRNewswire-FirstCall/ -- IsoTis, Inc. (NASDAQ:ISOT) ("IsoTis"), an orthobiologics company...
Less Than 100,000 Additional "FOR" Votes Required for Integra Merger IRVINE, California, October 26 /PRNewswire-FirstCall/ -- IsoTis, Inc. (NASDAQ:ISOT) ("IsoTis"), an orthobiologics company...
Less Than 350,000 Additional Votes "FOR" Required for Integra Merger IRVINE, California, October 24 /PRNewswire-FirstCall/ -- IsoTis, Inc. (NASDAQ:ISOT) ("IsoTis"), an orthobiologics company...
Conference Calls to Answer Questions About Stockholder Meeting October 23 IRVINE, California, October 16 /PRNewswire-FirstCall/ -- IsoTis, Inc. (NASDAQ:ISOT) ("IsoTis"), an orthobiologics...
IRVINE, California, October 16 /PRNewswire-FirstCall/ -- - Conference Calls to Answer Questions About Stockholder Meeting October 23 IsoTis, Inc. (NASDAQ:ISOT) ("IsoTis"), an orthobiologics...
IRVINE, California, October 11 /PRNewswire-FirstCall/ -- IsoTis, Inc. (NASDAQ:ISOT) ("IsoTis"), an orthobiologics company, today announced that it has adjourned the special meeting of...
Leading Proxy Advisor Recommends Shareholders Support Merger IRVINE, California, September 19 /PRNewswire-FirstCall/ -- IsoTis, Inc. (NASDAQ:ISOT) ("IsoTis"), an orthobiologics company, today...
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 156 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 260 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| Aucune Discussion Trouvée |
| Ajouter une Discussion |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
